Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism
Fundamental & Clinical Pharmacology · 2024-06 · 38 (3) · 489-501
DOI: 10.1111/fcp.12983 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 04.02.2024. Verfasst von Ivan A Derkachev und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk NRMC, Tomsk, Russia. Hauptthemen laut MEDLINE: Angiotensin I, Peptide Fragments, Myocardial Reperfusion Injury, Signal Transduction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Background
The high mortality rate of patients with acute myocardial infarction (AMI) remains the most pressing issue of modern cardiology. Over the past 10 years, there has been no significant reduction in mortality among patients with AMI. It is quite obvious that there is an urgent need to develop fundamentally new drugs for the treatment of AMI. Angiotensin 1–7 has some promise in this regard.
Objective
The objective of this article is analysis of published data on the cardioprotective properties of angiotensin 1–7.
Methods
PubMed, Scopus, Science Direct, and Google Scholar were used to search articles for this study.
Results
Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart. Angiotensin 1–7 can prevent not only ischemic but also reperfusion cardiac injury. The activation of the Mas receptor plays a key role in these effects of angiotensin 1–7. Angiotensin 1–7 alleviates Ca 2+ overload of cardiomyocytes and reactive oxygen species production in ischemia/reperfusion (I/R) of the myocardium. It is possible that both effects are involved in angiotensin 1–7‐triggered cardiac tolerance to I/R. Furthermore, angiotensin 1–7 inhibits apoptosis of cardiomyocytes and stimulates autophagy of cells. There is also indirect evidence suggesting that angiotensin 1–7 inhibits ferroptosis in cardiomyocytes. Moreover, angiotensin 1–7 possesses anti‐inflammatory properties, possibly achieved through NF‐kB activity inhibition. Phosphoinositide 3‐kinase, Akt, and NO synthase are involved in the infarct‐reducing effect of angiotensin 1–7. However, the specific end‐effector of the cardioprotective impact of angiotensin 1–7 remains unknown.
Conclusion
The molecular nature of the end‐effector of the infarct‐limiting effect of angiotensin 1–7 has not been elucidated. Perhaps, this end‐effector is the sarcolemmal K ATP channel or the mitochondrial K ATP channel.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk NRMC, Tomsk, Russia.
- Department of Biophysics and Functional Diagnostics, Siberian State Medical University, Tomsk, Russia.
- Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, School of Basic Medicine, The Fourth Military Medical University, Xi'an, China.
ORCID-Profile: Leonid N Maslov, Alexandr V Mukhomedzyanov, Natalia V Naryzhnaya
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Derkachev, I. A., Popov, S. V., Maslov, L. N., Mukhomedzyanov, A. V., Naryzhnaya, N. V., Gorbunov, A. S., Kan, A., Krylatov, A. V., Podoksenov, Y. K., Stepanov, I. V., Gusakova, S. V., Fu, F., & Pei, J. M. (2024). Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism. Fundamental & Clinical Pharmacology, 38(3), 489-501. https://doi.org/10.1111/fcp.12983
Vancouver
Derkachev IA, Popov SV, Maslov LN, Mukhomedzyanov AV, Naryzhnaya NV, Gorbunov AS, et al. Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism. Fundamental & Clinical Pharmacology. 2024;38(3):489-501. doi:10.1111/fcp.12983
BibTeX
@article{Derkachev2024,
author = {Derkachev, Ivan A and Popov, Sergey V and Maslov, Leonid N and Mukhomedzyanov, Alexandr V and Naryzhnaya, Natalia V and Gorbunov, Alexander S and Kan, Artur and Krylatov, Andrey V and Podoksenov, Yuri K and Stepanov, Ivan V and Gusakova, Svetlana V and Fu, Feng and Pei, Jian-Ming},
title = {Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism},
journal = {Fundamental & Clinical Pharmacology},
year = {2024},
volume = {38},
number = {3},
pages = {489--501},
doi = {10.1111/fcp.12983}
}
EUVIMED